Finance

Lists
Why is UNCY down 2,63%?
Dive Deeper
UNCY:NASDAQ
Unicycive Therapeutics Inc
4,07 $
-2,63%
(-0,11) 1D
4,07 $
0,00% (0,00)
After hours
Closed: 8 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for UNCY...
Open
4,16 $
High
4,20 $
Low
4,03 $
Mkt. cap
113,37 մլն
Avg. vol.
856,80 հզր
Volume
0,00
52-wk high
8,74 $
52-wk low
3,99 $
EPS
-1,62 $
Beta
1,83
Shares outstanding
27,86 մլն
No. of employees
22
Open
4,16 $
High
4,20 $
Low
4,03 $
Mkt. cap
113,37 մլն
Avg. vol.
856,80 հզր
Volume
0,00
52-wk high
8,74 $
52-wk low
3,99 $
EPS
-1,62 $
Beta
1,83
Shares outstanding
27,86 մլն
No. of employees
22
News stories
From web sources and news partners
About Unicycive Therapeutics Inc
CEO-
Employees22
Founded2016
Headquarters-
Sector-
Websiteunicycive.com
Analyst ratings
Based on 6 analysts giving stock ratings to UNCY in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for UNCY in the last 3 months.
Highest
Current 4,07 $
50,00 $ (+1 128,50%)
Average
25,50 $ (+526,54%)
Lowest
13,00 $ (+219,41%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
13,00 $
+219,4%
09/30/2026
Bruce Jackson
StoneX
Buy
Maintained
15,00 $
+268,6%
08/20/2026
Jason McCarthy
Maxim Group
Buy
Maintained
30,00 $
+637,1%
08/17/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
20,00 $
+391,4%
08/13/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
50,00 $
+1 128,5%
08/13/2026
Vamil Divan
Guggenheim
Buy
Maintained
25,00 $
+514,3%
08/12/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
90,00 $
+2 111,3%
06/01/2026
Unknown Analyst
Westpark Capital
Buy
Initiated
72,00 $
+1 669%
02/19/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2,96 մլն
2,25 մլն
1,61 մլն
2,79 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,38 մլն
4,97 մլն
6,83 մլն
7,35 մլն
Operating expense
7,34 մլն
7,22 մլն
8,44 մլն
10,14 մլն
Total operating expenses
7,34 մլն
7,22 մլն
8,44 մլն
10,14 մլն
Operating income
-7,34 մլն
-7,22 մլն
-8,44 մլն
-10,14 մլն
Other non operating income
1,07 մլն
-7,77 մլն
-4,78 մլն
7,98 մլն
EBT including unusual items
-6,01 մլն
-14,67 մլն
-12,82 մլն
-1,72 մլն
EBT excluding unusual items
-6,01 մլն
-14,67 մլն
-12,82 մլն
-1,72 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6,01 մլն
-14,67 մլն
-12,82 մլն
-1,72 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,33
-0,82
-0,54
-0,06
Interest and investment income
279,00 հզր
351,00 հզր
394,00 հզր
441,00 հզր
Interest expense
-15,00 հզր
-27,00 հզր
-
-
Net interest expenses
264,00 հզր
324,00 հզր
394,00 հզր
441,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-7,33 մլն
-7,21 մլն
-8,43 մլն
-10,13 մլն
Gain or loss from assets sale
-
-
18,00 հզր
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps